Asia Pacific Radiotherapy Market by Type and by Application
The Asia-Pacific Radiotherapy Market was worth $1,144.5 million in 2016 and estimated to be growing at a CAGR of 6.82%, to reach $1,591.7 million by 2021.
(EMAILWIRE.COM, September 08, 2017 ) According to the report Asia Pacific Radiotherapy market, published by Market Data Forecast, the Market was worth USD 1,144.5 million in 2016 and estimated to be growing at a CAGR of 6.82%, to reach USD 1,591.7 million by 2021. Asia-Pacific radiotherapy market is expected to observe highest growth rate during the forecast period owing to a number of factors comprising refining healthcare infrastructure and supportive government activities.
In the present global state where number of people bearing with different types of cancer is on the growth, the applications of new and upgraded as well as conventional forms of radiotherapy are enormous. The supreme important necessity requiring the development of improved and progressively precise radiation therapy is the requirement to exactly hit only the affected tumor using the radiation beam and avoid harming the surrounding tissue.
Browse market data tables and in-depth TOC of the Asia Pacific Radiotherapy Industry to 2021 @ http://www.marketdataforecast.com/market-reports/asia-pacific-radiotherapy-market-818/request-sample
Increase in number of elderly population, technological innovations in radiotherapy products, rising conferences driving investments in radiotherapy, growing incidence of cancer incidences and mounting acceptance of radiotherapy devices and procedures will majorly drive the radiotherapy market. Though, the absence of trained personnel to perform the therapy, practiced alternative therapy, its incapability to be used for metastasis state of cancer and side effects associated with the treatment restrained the market growth.
Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/asia-pacific-radiotherapy-market-818/request-sample
The Asia-Pacific radiotherapy market is segmented on the basis of type into External beam radiation therapy, internal beam radiation therapy and systemic radiation therapy. External beam radiation therapy is sub segmented into Intensity-modulated radiation therapy (IMRT), Image-guided radiation therapy (IGRT), Tomotherapy, Stereotactic radiosurgery, Stereotactic body radiation therapy and Proton therapy. Based on application the market is segregated into Skin & Lip Cancer, Head & Neck Cancer, Breast Cancer, Prostate Cancer, Cervical Cancer, Lung Cancer and Spine Cancer. On the basis of equipment type market is bifurcated into Linear accelerators, Radiation therapy simulators and Treatment planning systems. The prostate cancer application segment is estimated to hold the largest share in both external beam radiotherapy market along with internal radiotherapy market.
Based on geography the market is analysed under various regions namely, China, India, Japan, South Korea and Australia. China is dominating the Asia-Pacific region radiotherapy market due to large number of elderly population in the country and is expected to continue its dominance.
Inquire before buying @ http://www.marketdataforecast.com/market-reports/asia-pacific-radiotherapy-market-818/inquire
Nordion Inc. (Canada), RaySearch Laboratories AB (Sweden), Ion Beam Applications SA (Belgium), C. R. Bard Inc. (U.S.), Mevion Medical Systems Inc. (U.S.), Varian Medical Systems Inc. (U.S.), IsoRay Medical Inc. (U.S.), Elekta AB (Sweden), Accuray Incorporated (U.S.), and Mitsubishi Electric Corporation (Japan) are the key players in the radiotherapy market.
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
In the present global state where number of people bearing with different types of cancer is on the growth, the applications of new and upgraded as well as conventional forms of radiotherapy are enormous. The supreme important necessity requiring the development of improved and progressively precise radiation therapy is the requirement to exactly hit only the affected tumor using the radiation beam and avoid harming the surrounding tissue.
Browse market data tables and in-depth TOC of the Asia Pacific Radiotherapy Industry to 2021 @ http://www.marketdataforecast.com/market-reports/asia-pacific-radiotherapy-market-818/request-sample
Increase in number of elderly population, technological innovations in radiotherapy products, rising conferences driving investments in radiotherapy, growing incidence of cancer incidences and mounting acceptance of radiotherapy devices and procedures will majorly drive the radiotherapy market. Though, the absence of trained personnel to perform the therapy, practiced alternative therapy, its incapability to be used for metastasis state of cancer and side effects associated with the treatment restrained the market growth.
Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/asia-pacific-radiotherapy-market-818/request-sample
The Asia-Pacific radiotherapy market is segmented on the basis of type into External beam radiation therapy, internal beam radiation therapy and systemic radiation therapy. External beam radiation therapy is sub segmented into Intensity-modulated radiation therapy (IMRT), Image-guided radiation therapy (IGRT), Tomotherapy, Stereotactic radiosurgery, Stereotactic body radiation therapy and Proton therapy. Based on application the market is segregated into Skin & Lip Cancer, Head & Neck Cancer, Breast Cancer, Prostate Cancer, Cervical Cancer, Lung Cancer and Spine Cancer. On the basis of equipment type market is bifurcated into Linear accelerators, Radiation therapy simulators and Treatment planning systems. The prostate cancer application segment is estimated to hold the largest share in both external beam radiotherapy market along with internal radiotherapy market.
Based on geography the market is analysed under various regions namely, China, India, Japan, South Korea and Australia. China is dominating the Asia-Pacific region radiotherapy market due to large number of elderly population in the country and is expected to continue its dominance.
Inquire before buying @ http://www.marketdataforecast.com/market-reports/asia-pacific-radiotherapy-market-818/inquire
Nordion Inc. (Canada), RaySearch Laboratories AB (Sweden), Ion Beam Applications SA (Belgium), C. R. Bard Inc. (U.S.), Mevion Medical Systems Inc. (U.S.), Varian Medical Systems Inc. (U.S.), IsoRay Medical Inc. (U.S.), Elekta AB (Sweden), Accuray Incorporated (U.S.), and Mitsubishi Electric Corporation (Japan) are the key players in the radiotherapy market.
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Contact Information:
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results